Back to search

Article

ARNTL2, an Immunoregulation-Related Prognostic Biomarker in Pan-Cancer and Lung Adenocarcinoma

2021-11-23

Abstract excerpt

<title>Abstract</title> <p>Background ARNTL2 is a member of the PAS superfamily that promotes tumor progression. However, the role of ARNTL2 in lung adenocarcinoma (LUAD) remains unclear. The purpose of our study was to investigate the function of ARNTL2 in LUAD. Methods The expression, clinical features, and prognostic role of ARNTL2 in pan-cancer were evaluated using The Cancer Genome Atlas and Genotype-Tissu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
149cef62-2f3f-50e3-8264-4d466e50e0f4
DOI
10.21203/rs.3.rs-1065822/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ARNTL2, an Immunoregulation-Related Prognostic Biomarker in Pan-Cancer and Lung AdenocarcinomaDOI 10.21203/rs.3.rs-1065822/v1
Select a neighboring publication to make it the new centre.